188 related articles for article (PubMed ID: 28934252)
21. REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.
Orta-Salazar E; Aguilar-Vázquez A; Martínez-Coria H; Luquín-De Anda S; Rivera-Cervantes M; Beas-Zarate C; Feria-Velasco A; Díaz-Cintra S
Life Sci; 2014 Oct; 116(2):83-9. PubMed ID: 25261598
[TBL] [Abstract][Full Text] [Related]
22. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice.
España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA
Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757
[TBL] [Abstract][Full Text] [Related]
23. RNA-Seq analysis of frontal cortex and cerebellum from 5XFAD mice at early stage of disease pathology.
Kim KH; Moon M; Yu SB; Mook-Jung I; Kim JI
J Alzheimers Dis; 2012; 29(4):793-808. PubMed ID: 22507954
[TBL] [Abstract][Full Text] [Related]
24. Evidence for altered Numb isoform levels in Alzheimer's disease patients and a triple transgenic mouse model.
Chigurupati S; Madan M; Okun E; Wei Z; Pattisapu JV; Mughal MR; Mattson MP; Chan SL
J Alzheimers Dis; 2011; 24(2):349-61. PubMed ID: 21258150
[TBL] [Abstract][Full Text] [Related]
25. Distinct Expression of Long Non-Coding RNAs in an Alzheimer's Disease Model.
Lee DY; Moon J; Lee ST; Jung KH; Park DK; Yoo JS; Sunwoo JS; Byun JI; Shin JW; Jeon D; Jung KY; Kim M; Lee SK; Chu K
J Alzheimers Dis; 2015; 45(3):837-49. PubMed ID: 25624420
[TBL] [Abstract][Full Text] [Related]
26. Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo.
Gandy S; Zhang YW; Ikin A; Schmidt SD; Bogush A; Levy E; Sheffield R; Nixon RA; Liao FF; Mathews PM; Xu H; Ehrlich ME
J Neurochem; 2007 Aug; 102(3):619-26. PubMed ID: 17630980
[TBL] [Abstract][Full Text] [Related]
27. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
28. Early neuronal loss and axonal/presynaptic damage is associated with accelerated amyloid-β accumulation in AβPP/PS1 Alzheimer's disease mice subiculum.
Trujillo-Estrada L; Dávila JC; Sánchez-Mejias E; Sánchez-Varo R; Gomez-Arboledas A; Vizuete M; Vitorica J; Gutiérrez A
J Alzheimers Dis; 2014; 42(2):521-41. PubMed ID: 24927710
[TBL] [Abstract][Full Text] [Related]
29. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease.
Duncan MJ; Smith JT; Franklin KM; Beckett TL; Murphy MP; St Clair DK; Donohue KD; Striz M; O'Hara BF
Exp Neurol; 2012 Aug; 236(2):249-58. PubMed ID: 22634208
[TBL] [Abstract][Full Text] [Related]
30. Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease.
Kobayashi DT; Chen KS
Genes Brain Behav; 2005 Apr; 4(3):173-96. PubMed ID: 15810905
[TBL] [Abstract][Full Text] [Related]
31. Geniposide attenuates insulin-deficiency-induced acceleration of β-amyloidosis in an APP/PS1 transgenic model of Alzheimer's disease.
Zhang Y; Yin F; Liu J; Liu Z; Guo L; Xia Z; Zidichouski J
Neurochem Int; 2015 Oct; 89():7-16. PubMed ID: 25882165
[TBL] [Abstract][Full Text] [Related]
32. Proteome characterization of splenocytes from an Aβpp/ps-1 Alzheimer's disease model.
Cao Z; Robinson RA
Proteomics; 2014 Feb; 14(2-3):291-7. PubMed ID: 24293237
[TBL] [Abstract][Full Text] [Related]
33. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
[TBL] [Abstract][Full Text] [Related]
34. Differential cell proliferation in the cortex of the APPswePS1dE9 Alzheimer's disease mouse model.
Kamphuis W; Orre M; Kooijman L; Dahmen M; Hol EM
Glia; 2012 Apr; 60(4):615-29. PubMed ID: 22262260
[TBL] [Abstract][Full Text] [Related]
35. An integrated genetics approach for identifying protein signal pathways of Alzheimer's disease.
Huang Y; Sun X; Hu G
Comput Methods Biomech Biomed Engin; 2011 Apr; 14(4):371-8. PubMed ID: 21442495
[TBL] [Abstract][Full Text] [Related]
36. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
Pan X; Gong N; Zhao J; Yu Z; Gu F; Chen J; Sun X; Zhao L; Yu M; Xu Z; Dong W; Qin Y; Fei G; Zhong C; Xu TL
Brain; 2010 May; 133(Pt 5):1342-51. PubMed ID: 20385653
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
[TBL] [Abstract][Full Text] [Related]
38. Biological transgenic mouse models of Alzheimer's disease.
Crews L; Rockenstein E; Masliah E
Handb Clin Neurol; 2008; 89():291-301. PubMed ID: 18631753
[No Abstract] [Full Text] [Related]
39. Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer's disease transgenic mice.
Cheng D; Spiro AS; Jenner AM; Garner B; Karl T
J Alzheimers Dis; 2014; 42(4):1383-96. PubMed ID: 25024347
[TBL] [Abstract][Full Text] [Related]
40. Spatial Memory Impairment is Associated with Intraneural Amyloid-β Immunoreactivity and Dysfunctional Arc Expression in the Hippocampal-CA3 Region of a Transgenic Mouse Model of Alzheimer's Disease.
Morin JP; Cerón-Solano G; Velázquez-Campos G; Pacheco-López G; Bermúdez-Rattoni F; Díaz-Cintra S
J Alzheimers Dis; 2016; 51(1):69-79. PubMed ID: 26836189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
